Retinal Vascular Diseases Flashcards
Pathogenesis of Diabetic Retinopathy
Hyperglycaemia intiates microangiopathy where following events will take place in the retina,
• Degeneration and loss of pericytes, proliferation of endothelial cells, thickening of basement membrane and occlusion
• Leakage resulting in retinal oedema and hard exudates
• Decreased capillary flow
• Retinal Hypoxia cause IRMA and neovas
Signs of Diabetic Retinopathy
Microaneurysms, retinal haemorrhage, hard exudates, cotton wool spots, venous changes, intraretinal microvascular abnormalities, neovascularisation, pre-retinal haemorrhages, diabetic macular oedema, clinically significant macular oedema
Difference between dot and blot haemorrhages and flame-shaped haemorrhages
Dot and blot between INL and OPL
Flame shaped in NFL
Signs of Clinically Significant Macular Oedema
- Retinal oedema within 500um of the centre of macular
- Hard exudates within 500um of the centre of macular if adjacent retina thickens
- Retina oedema one disc area or larger
Severity of NPDR
Very mild: Microaneurysms
Mild: Microaneurysms, haemorrhages, etc but no IRMA
Moderate: Severe haemorrhages/ mild IRMA, venous beading in one quadrant, common cotton wool spots
Severe: 4-2-1, all haemorrhages, 2 venous beading, 1 moderate IRMA
Very Severe: 2 more of the criteria of severe
Managements for different severity of NPDR
advise to control diabetes and risk factors
mild: no treATMENT and annual review
moderate: monitor for CSMO
severe: laser therapy if followup not avail
intravitreal anti VEGF agents
Proliferative Diabetic Retinopathy Pathogenesis
Primary feature of PDR is neovascularisation which is caused by angiogenic growth factors released by hypoxic retinal tissue in an attempt to re-vascularise hypoxic retina
Angiogenic stimulators such as VEGF promote neovas on retina, ONH and on iris
Management for PDR and CSMO
Severe PDR: intra-vitreal anti-VEGF injection, Laser Pan-retinal photocoagulation, vitrectomy
CSMO: Macular grid laser to limit vision loss
Pathogenesis for Retinal Vein Occlusion
- Arteriolosclerosis is an important causative factor for branch and central retinal vein occlusion
- Because a retinal arteriole and its corresponding vein share an adventitial sheath, thickening the arteriole appears to compress the vein
- This causes occlusion of the veins and the elevation of venous and capillary pressure with stagnation of blood flow
- This causes hypoxia of the retina
Retinal Vein Occlusion risk factors
Advancing age, Hypertension, Hyperlipidaemia, Diabetes, Raised IOP, Oral contraceptive pill
Branch Retinal Vein Occlusion Signs
VA is variable, Dilation and tortuosity, flame-shaped, dot and blot haemorrhages, retinal oedema, cotton wool spots
Branch Retinal Vein Occlusion Course
Acute features takes 6-12 months to resolve and replaced with hard exudates, venous sheathing and sclerosis
Collaterals which may be local
Branch Retinal Vein Occlusion Prognosis
Reasonably good, in 6 months 50% va will better than 6/12
Branch Retinal Vein Occlusion Managements
Refer to ophthalmologist to monitor for sight threatening conditions. eg. macular oedema, neovas
Non-Ischaemic Central Retinal Vein Occlusion Signs
VA: moderate to severe reduction
APD: absent or mild
Tortuosity or dilation of all retinal veins
Dot and blot, flame shaped haemorrhages, disc and macular oedema, cotton wool spots